Adverse Event Reporting in Otolaryngology

被引:1
|
作者
Pereira, Nicola M. [1 ]
Sclafani, Anthony P. [2 ]
Kacker, Ashutosh [2 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
[2] Weill Cornell Med, Dept Otolaryngol Head & Neck Surg, New York, NY USA
来源
LARYNGOSCOPE | 2021年 / 131卷 / 03期
关键词
Adverse event reporting; otolaryngology; quality improvement; US HOSPITALS; ERRORS; UTAH;
D O I
10.1002/lary.28861
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives Adverse events are common occurrences in hospitals that detract from quality of care. There are few data on errors in otolaryngology (ENT) and even fewer data comparing ENT to other services. Methods We retrospectively reviewed adverse event data collected across a regional hospital network from July 2014 to August 2017. We examined categories of adverse events that occurred most commonly in ENT and compared the number of adverse events reported in ENT to those reported across all other departments. Descriptive analysis and the pairedttest were used to analyze the data. Results Two hundred ninety-one adverse events were reported in ENT departments during the period studied compared to 58,219 events reported across all other specialties. In ENT, the most commonly reported adverse events occurred in the perioperative setting, followed by issues regarding equipment and medical devices and, lastly, airway management. Across all other departments, the most common categories included medication and fluid errors, falls, and safety and security events. ENT departments had significantly higher proportions of perioperative and airway management errors and significantly lower proportions of events related to diagnosis and treatment (P = .004), falls (P < .001), lab results and specimens (P = .001), medication and fluids (P < .001), and safety and security (P < .001). Conclusion Perioperative and airway management errors occur with a statistically higher frequency in ENT compared to other in-patient and out-patient departments across hospitals. It is important to analyze adverse event reporting in surgical specialties to ensure the development of appropriate quality initiatives. Level of Evidence 4Laryngoscope, 2020
引用
收藏
页码:509 / 512
页数:4
相关论文
共 50 条
  • [41] IN VIDEO, FDA URGES ADVERSE EVENT REPORTING
    Cima, Greg
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 259 (03): : 223 - 223
  • [42] Seasonal and Geographic Variation In Adverse Event Reporting
    Hauben, M.
    Hung, E.
    Marrero, O.
    DRUG SAFETY, 2015, 38 (10) : 987 - 988
  • [43] Adverse Event Reporting - How Robust is the System?
    Gambhir, R.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 163 - 163
  • [44] Reporting of Clinical Adverse Events Scale: a measure of doctor and nurse attitudes to adverse event reporting
    Wilson, B.
    Bekker, H. L.
    Fylan, F.
    QUALITY & SAFETY IN HEALTH CARE, 2008, 17 (05): : 364 - 367
  • [45] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
    Pankdeep Chhabra
    Xing Chen
    Sheila R. Weiss
    Drug Safety, 2013, 36 : 1117 - 1123
  • [46] Reporting adverse events at geriatric facilities Categorization by type of adverse event and function of reporting personnel
    Shmueli, Tali
    Noy, Ronit Har
    Ben Natan, Merav
    Ben-Israel, Joshua
    INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2014, 27 (02) : 91 - +
  • [47] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
    Chhabra, Pankdeep
    Chen, Xing
    Weiss, Sheila R.
    DRUG SAFETY, 2013, 36 (11) : 1117 - 1123
  • [48] Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline
    Chedid, Victor
    Vijayvargiya, Priya
    Camilleri, Michael
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 336 - 338
  • [49] Promoting Spontaneous Adverse Event Reporting in Morocco: The national Reporting Day
    Soulaymani, R.
    Sefiani, H.
    Benabdallah, G.
    Tebaa, A.
    DRUG SAFETY, 2019, 42 (10) : 1233 - 1233
  • [50] An evaluation of the FDA adverse event reporting system and the potential for reporting bias
    Monnot, Andrew D.
    Fung, Ernest S.
    Compoginis, Goli S.
    Towle, Kevin M.
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1849 - 1854